Printer Friendly
The Free Library
14,635,145 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/Biomira Inc. Annual General Meeting; Biomira to Highlight Merck KGaA Co-Promotion Collaboration At Annual General Meeting.


Business Editors/Biotechnology Writers

ADVISORY...For Wednesday Wednesday: see week. , May 23

--(BUSINESS WIRE)


What:     The Annual General Meeting of the Shareholders. The
          meeting will conduct the business of the corporation,
          which includes election of the directors and
          appointment of the auditors. Discussions will highlight
          the Biomira/Merck KGaA co-promotion collaborative
          agreement announced May 3, 2001. The highlights of this
          agreement coupled with milestones over the past year
          will be discussed. The President of the Company, Dr.
          Alex McPherson, will also discuss the vision for moving
          Biomira forward.

When:     Wednesday, May 23, 2001 - 4:00 - 5:30 p.m. E.S.T.

Where:    The Toronto Stock Exchange, TSE Conference Centre and
          Stock Market Place, 130 King Street West, Toronto,
          Ontario

          The Annual General Meeting will also be webcast at
          www.biomira.com. There will be a link on the front page that
          will take you directly to the webcast.

Who:      Mr. Eric Baker, Chairman of the Board, Biomira Inc.
          Dr. Alex McPherson, President and CEO Biomira Inc.


To RSVP (ReSerVation Protocol) A communications protocol that signals a router to reserve bandwidth for real time transmission. RSVP is designed to clear a path for audio and video traffic, eliminating annoying skips and hesitations.  or for further information, contact: Bill Wickson, Manager, Public Relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most , (780) 490-2818 or toll free 1-877-234-0444 ext. 818 or bwickson@biomira.com
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:May 22, 2001
Words:188
Previous Article:IPNet Accelerates Shift to Cutting-Edge Java Technology With UCI Extension; IPNet Engineers Pursue Java Enterprise Certification Program.
Next Article:Emergin Delivers Wireless Connectivity to Microsoft Great Plains Solomon Customers.
Topics:



Related Articles
BIOMIRA INC. SHAREHOLDER RIGHTS PLAN APPROVED.
BIOMIRA INC. ALMIRIA CONFIRMS STAND-BY COMMITMENT.
BIOMIRA TO ACQUIRE ONCOTHERAPEUTICS.
ImClone Systems and Merck KGaA Expand Collaboration with North American Co-Marketing Deal for ImClone's BEC2 Cancer Vaccine.
InvestPrivate, Inc. Announces Investment Opinion on Biomira, Inc.
Fourth Consecutive Year of Profitability Reported by IDEC Pharmaceuticals; Revenue Growth of 76 Percent for Year 2001.
IDEC Pharmaceuticals Reports Fifth Consecutive Year of Profitability With Earnings Per Share Increasing to $0.85 Per Diluted Share and Revenue Growth...
Webcast Alert: Biomira Inc. Presentation at Informed Investors Biotechnology/Cancer Stocks Virtual Forum to be Webcast on Thursday, November 4, 2004,...
Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Biomira, Inc. With A Market Outperform Rating.
SLOAN CANCER VACCINE PHASE III STUDY BEGINS.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles